ArticleBMC ophthalmology2015

1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy.

Ian Y Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.